Key result
Rupintrivir demonstrated cross-genotypic anti-norovirus activity in vitro, clearing human cells from their Norwalk replicon after two passages and inhibiting the human norovirus protease.
Why the study?
Does rupintrivir inhibit norovirus replication in vitro?
Population
In vitro models of norovirus including murine noroviruses, human cells with Norwalk replicon, and…
Design
Preclinical
Authors
Loading...
Supports rupintrivir as norovirus antiviral candidate; leaves open in vivo efficacy and clinical translation.
Does rupintrivir inhibit norovirus replication in vitro?
Rupintrivir demonstrates cross-genotypic anti-norovirus activity in vitro, suggesting potential as a therapeutic or prophylactic agent for norovirus infections.
Rocha‐Pereira et al. (2014) studied Norovirus infection. Rupintrivir was evaluated on in vitro anti-norovirus activity. Rupintrivir demonstrated cross-genotypic anti-norovirus activity in vitro, clearing human cells from their Norwalk replicon after two passages and inhibiting the human norovirus protease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: